Chikungunya fever in patients on biotherapies;Fièvre chikungunya chez les patients sousbiothérapie

Revue du Rhumatisme (Edition Francaise)

Volumn 83, Issue 1, 2016, Pages 75-76

  Brunier, Lauren ^a   Polomat, Katleen ^a   Deligny, Christophe ^a   Dehlinger, Veronique ^a   Numeric, Patrick ^a   Jean Baptiste, Georges ^a   Arfi, Serge ^a   De Bandt, Michel ^a  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE FORT DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ANALGESIC AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; GLUCOCORTICOID; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; MYCOPHENOLATE MOFETIL; TOCILIZUMAB; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

BIOLOGICAL THERAPY; CHIKUNGUNYA; CORTICOSTEROID THERAPY; DISEASE EXACERBATION; HUMAN; LETTER; POLYMERASE CHAIN REACTION; SEROLOGY; SPONDYLARTHRITIS; ADVERSE EFFECTS; ARTHRITIS; AUTOIMMUNE DISEASES; CHEMICALLY INDUCED; CHIKUNGUNYA FEVER; FEMALE; MALE;

ARTHRITIS; AUTOIMMUNE DISEASES; BIOLOGICAL THERAPY; CHIKUNGUNYA FEVER; FEMALE; HUMANS; MALE;

EID: 84959512233     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbspin.2015.08.004     Document Type: Letter

References (3)

1. Burt F, Chen W, Mahalingam S. Chikungunya virus and arthritic disease. LancetInfect Dis 2014;14:789-90.
2. Ali Ou Alla S, Combe B. Arthritis after infection with chikungunya virus. BestPract Res Clin Rheumatol 2011;25:337-46.
3. Mathew AJ, Goyal V, George E, et al. Rheumatic-musculoskeletal pain and disor-ders in a naïve group of individuals 15 months following a chikungunya viralepidemic in south India: a population based observational study. Int J Clin Pract2011;65:1306-12.